[1]徐通洁,朱俊龙,余皓,等.平行支架技术治疗主髂动脉闭塞性疾病中远期效果分析[J].介入放射学杂志,2024,33(12):1339-1344.
　XU Tongjie,ZHU Junlong,YU Hao,et al.Parallel stenting technique for occlusive disease of the aortoiliac artery：analysis of its medium-to-long-term efficacy[J].journal interventional radiology,2024,33(12):1339-1344.

点击复制

平行支架技术治疗主髂动脉闭塞性疾病中远期效果分析()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］Liang HL，Li MF，Hsiao CC，et al.Endovascular management of aorto-iliac occlusive disease （Leriche syndrome）［J］.J Formos Med Assoc，2021，120：1485-1492.
［2］Yang M，Zhang B，Niu G，et al.Long-term results of endovascular reconstruction for aortoiliac occlusive disease［J］.Quant Imaging Med Surg，2021，11：1303-1312.
［3］Shen C，Zhang Y，Qu C，et al.Outcomes of total aortoiliac revascularization for TASC-Ⅱ C&D lesion with kissing self-expanding covered stents［J］.Ann Vasc Surg，2020，68：434-441.
［4］倪其泓，陈佳佺，吕磊.等.覆膜支架腔内介入治疗主髂动脉闭塞20例临床效果［J］.介入放射学杂志，2018，27：118-121.
［5］Groot Jebbink E，Holewijn S，Slump CH，et al.Systematic review of results of kissing stents in the treatment of aortoiliac occlusive disease［J］.Ann Vasc Surg，2017，42：328-336.
［6］张帆，佟铸，郭连瑞，等.361例主髂动脉闭塞症外科治疗的临床疗效分析［J］.中国血管外科杂志（电子版），2022，14：12-17.
［7］Groot J E，Holewijn S，Versluis M et al.Meta-analysis of individual patient data after kissing stent treatment for aortoiliac occlusive disease［J］.J Endovasc Ther，2019，26：31-40.
［8］沈晨阳，张永保，房杰，等.主髂动脉闭塞症腔内治疗新进展［J］.中华外科杂志，2022，60：117-121.
［9］魏小龙，吴雅妮，孙羽东，等.平肾主动脉-髂动脉闭塞性病变腔内治疗［J］.介入放射学杂志，2016，25：387-390.
［10］Borghese O，Ferrer C，Coscarella C，et al.Two-year single centre results with covered endovascularreconstruction of aortic bifurcation （CERAB） in the treatment of extensive aorto-iliac occlusive disease［J］.Vascular，2022，30：500-508.
［11］Quan C，Kim DH，Jung HJ，et al.Comparison of results between kissing stent and aortic bifurcated bypass in aortoiliac occlusive disease［J］.Asian J Surg，2020，43：186-192.
［12］贾鑫，郭伟，刘小平，等.C/D级主髂动脉病变腔内治疗的中远期结果［J］.中华医学杂志，2020，100：2273-2277.
［13］Squizzato F，Piazza M，Pulli R，et al.Covered versus bare metal kissing stents for Reconstruction of the aortic bifurcation in the ILIACS registry［J］.J Vasc Surg，2021，73：1980-1990.e4.
［14］卫任，郭伟.覆膜支架和裸支架在主髂动脉闭塞症腔内治疗中的循证与经验［J］.中华血管外科杂志，2023，8：13-16.
［15］Li J，Shen C，Zhang Y，et al.Outcomes of covered vs bare metal stents for the treatment of aortoiliac occlusive disease［J］.J Vasc Surg，2024，79：330-338.
［16］李艳奎，吴义生，张小明.TASC-D型下肢动脉硬化闭塞症腔内治疗现状［J］.介入放射学杂志，2015，24：544-547.
［17］王贵明，杨钰栋，马宏刚，等.泛大西洋协作组织ⅡD型主髂动脉闭塞性疾病腔内治疗的疗效分析［J］.中华老年多器官疾病杂志，2020，19：38-41.
［18］Piazza M，Squizzato F，Spolverato G，et al.Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions［J］.J Vasc Surg，2015，62：1210-1218.e1.
［19］Javed IN，Hawkins BM.Aorto-iliac peripheral artery disease［J］.Prog Cardiovasc Dis，2021，65：9-14.
［20］Aggarwal V，Waldo SW，Armstrong EJ.Endovascular revascularization for aortoiliac atherosclerotic disease［J］.Vasc Health Risk Manag，2016，12：117-127.
［21］Ye W，Liu CW，Ricco JB，et al.Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions［J］.J Vasc Surg，2011，53：1728-1737.
［22］Jongkind V，Akkersdijk GJ，Yeung KK，et al.A systematic review of endovascular treatment of extensive aortoiliac occlusive disease［J］.J Vasc Surg，2010，52：1376-1383.
［23］Mangialardi N，Ronchey S，Serrao E，et al.Endovascular management of total juxtarenal aortic occlusive disease in high-risk patients：technical considerations and clinical outcome［J］.J Cardiovasc Surg （Torino），2017，58：422-430.
［24］Moise MA，Alvarez-Tostado JA，Clair DG，et al.Endovascular management of chronic infrarenal aortic occlusion［J］.J Endovasc Ther，2009，16：84-92.
［25］Schmalstieg J，Zeller T，Tübler T，et al.Long term data of endovascularly treated patients with severe and complex aortoiliac occlusive disease［J］.J Cardiovasc Surg （Torino），2012，53：291-300.
［26］高海军，陈光，王浩，等.支架成形联合置管溶栓治疗TASC（Ⅱ）D型主髂动脉闭塞性疾病［J］.介入放射学杂志，2012，21：948-952.
［27］Marrocco-Trischitta MM，Bertoglio L，Tshomba Y，et al.The best treatment of juxtarenal aortic occlusion is and will be open surgery［J］.J Cardiovasc Surg （Torino），2012，53：307-312.
［28］李春民，冷瑞，任华亮，等：溶栓减容应用于主髂动脉闭塞病变的疗效分析［J］.中华普通外科杂志，2019，34：1044-1047.
［29］Kretschmann T，Usai MV，Taneva GT，et al.The role of open and endovascular treatment of patients with chronic aortoiliac Leriche syndrome［J］.Vascular，2020，28：68-73.
［30］刘蒙，张福先.主髂动脉闭塞症腔内治疗进展［J］.中国老年学杂志，2018，38：3068-3071.
［31］Wang C，Chen J，Shao J，et al.Ten-year experiences and outcomes of bypass surgery and endovascular therapy in the management of infrarenal aortic occlusion：a single-center retrospective cohort study［J］.Quant Imaging Med Surg，2023，13：7854-7865.
［32］Sixt S，Alawied AK，Rastan A，et al.Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification：a single-center experience［J］.J Endovasc Ther，2008，15：408-416.
［33］Hans SS，DeSantis D，Siddiqui R，et al.Results of endovascular therapy and aortobifemoral grafting for transatlantic inter-society type C and D aortoiliac occlusive disease［J］.Surgery，2008，144：583-589.
［34］Mwipatayi BP，Sharma S，Daneshmand A，et al.Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial （COBEST） for the treatment of aortoiliac occlusive disease［J］.J Vasc Surg，2016，64：83-94.e1.
［35］Nanto K，Iida O，Fujihara M，et al.Five-year patency and its predictors after endovascular therapy for aortoiliac occlusive disease［J］.J Atheroscler Thromb，2019，26：989-996.
［36］李京雨，刘涛，徐力扬，等.慢性主-髂动脉闭塞内膜下再通治疗的可行性及初步应用［J］.介入放射学杂志，2009，8：220-223.
［37］王鼎，贾龙元，赵成东，等.主髂动脉闭塞症开放手术与腔内治疗中远期疗效比较［J］.中华血管外科杂志，2023，8：32-36.